BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18560422)

  • 1. AAV8-mediated gene transfer of interleukin-4 to endogenous beta-cells prevents the onset of diabetes in NOD mice.
    Rehman KK; Trucco M; Wang Z; Xiao X; Robbins PD
    Mol Ther; 2008 Aug; 16(8):1409-16. PubMed ID: 18560422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of IL-2 in β cells by AAV8 gene transfer in pre-diabetic NOD mice prevents diabetes through activation of FoxP3-positive regulatory T cells.
    Flores RR; Zhou L; Robbins PD
    Gene Ther; 2014 Aug; 21(8):715-22. PubMed ID: 24849041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. dsAAV8-mediated gene transfer and β-cell expression of IL-4 and β-cell growth factors are capable of reversing early-onset diabetes in NOD mice.
    Gaddy DF; Riedel MJ; Bertera S; Kieffer TJ; Robbins PD
    Gene Ther; 2012 Aug; 19(8):791-9. PubMed ID: 22089495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.
    Hammond KJ; Poulton LD; Palmisano LJ; Silveira PA; Godfrey DI; Baxter AG
    J Exp Med; 1998 Apr; 187(7):1047-56. PubMed ID: 9529321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activity of immunoregulatory T cells mediating active tolerance is potentiated in nonobese diabetic mice by an IL-4-based retroviral gene therapy.
    Yamamoto AM; Chernajovsky Y; Lepault F; Podhajcer O; Feldmann M; Bach JF; Chatenoud L
    J Immunol; 2001 Apr; 166(8):4973-80. PubMed ID: 11290776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAV-mediated pancreatic overexpression of
    Mallol C; Casana E; Jimenez V; Casellas A; Haurigot V; Jambrina C; Sacristan V; Morró M; Agudo J; Vilà L; Bosch F
    Mol Metab; 2017 Jul; 6(7):664-680. PubMed ID: 28702323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal relationship between immune cell influx and the expression of inducible nitric oxide synthase, interleukin-4 and interferon-gamma in pancreatic islets of NOD mice following adoptive transfer of diabetic spleen cells.
    Reddy S; Karanam M; Krissansen G; Nitschke K; Neve J; Poole CA; Ross JM
    Histochem J; 2000 Apr; 32(4):195-206. PubMed ID: 10872884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes.
    Balasa B; La Cava A; Van Gunst K; Mocnik L; Balakrishna D; Nguyen N; Tucker L; Sarvetnick N
    J Immunol; 2000 Dec; 165(12):7330-7. PubMed ID: 11120869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of combined intervention with adenovirus vector mediated IL-10 and IGF-1 genes on endogenous islet β cells in nonobese diabetes mice with onset of type 1 diabetes mellitus.
    Zhang L; Chen Y; Li C; Lin X; Cheng X; Li T
    PLoS One; 2014; 9(3):e92616. PubMed ID: 24663217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice.
    Manzoor F; Johnson MC; Li C; Samulski RJ; Wang B; Tisch R
    Eur J Immunol; 2017 Jan; 47(1):144-154. PubMed ID: 27859048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of autoimmune diabetes by viral IL-10 gene transfer.
    Yang Z; Chen M; Wu R; Fialkow LB; Bromberg JS; McDuffie M; Naji A; Nadler JL
    J Immunol; 2002 Jun; 168(12):6479-85. PubMed ID: 12055268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice.
    Ko KS; Lee M; Koh JJ; Kim SW
    Mol Ther; 2001 Oct; 4(4):313-6. PubMed ID: 11592833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient gene delivery to human and rodent islets with double-stranded (ds) AAV-based vectors.
    Rehman KK; Wang Z; Bottino R; Balamurugan AN; Trucco M; Li J; Xiao X; Robbins PD
    Gene Ther; 2005 Sep; 12(17):1313-23. PubMed ID: 15858610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice.
    Johnson MC; Garland AL; Nicolson SC; Li C; Samulski RJ; Wang B; Tisch R
    Diabetes; 2013 Nov; 62(11):3775-84. PubMed ID: 23884888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.
    Hancock WW; Polanski M; Zhang J; Blogg N; Weiner HL
    Am J Pathol; 1995 Nov; 147(5):1193-9. PubMed ID: 7485382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion.
    Goudy KS; Burkhardt BR; Wasserfall C; Song S; Campbell-Thompson ML; Brusko T; Powers MA; Clare-Salzler MJ; Sobel ES; Ellis TM; Flotte TR; Atkinson MA
    J Immunol; 2003 Sep; 171(5):2270-8. PubMed ID: 12928371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
    Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
    J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
    Hussain S; Delovitch TL
    J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice.
    Cardozo AK; Proost P; Gysemans C; Chen MC; Mathieu C; Eizirik DL
    Diabetologia; 2003 Feb; 46(2):255-66. PubMed ID: 12627325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.